Research Paper Volume 11, Issue 19 pp 8463—8473
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)
Figure 7. OS by chemotherapy regimens and age group. (A) HRs for OS are presented by non-ANT-based versus ANT-based regimens in early-stage patients who received (A) CMT or (B) CT, and (C) in advanced-stage patients. The solid line represents the HR estimate, and dashed lines represent 95% CIs. OS, overall survival; HR, hazard ratio; ANT, anthracycline; CMT, combined modality therapy; CT, chemotherapy; CI, confidence interval.